Chrome Extension
WeChat Mini Program
Use on ChatGLM

Trial In Progress: Phase Ib/Ii Study Of Bcl-2/Bcl-Xl Inhibitor Pelcitoclax (Apg-1252) In Patients With Myelofibrosis (Mf) That Progressed After Initial Therapy

BLOOD(2020)

Cited 2|Views17
No score
Abstract
Background:
More
Translated text
Key words
myelofibrosis,inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined